Nobiletin inhibited migration and proliferation but promoted apoptosis of human breast cancer cells via Nrf2, p38 MAPK, and NF-ΚB pathway (Tsai et al., 2021; Liu J. et al., 2018). Here, NFE2L2 is linked to breast carcinoma.